C U R R I C U L U M V I T A E Vasile Daniel Conferențiar...

1

C U R R I C U L U M V I T A E

Vasile Daniel

Conferențiar universitar

Medic primar psihiatru

Doctor in stiinte medicale

Șef Clinică Psihiatrie

DATA NAȘTERII - 29.04.1963

STUDII - Facultatea de Medicină Militară, I.M.F. București, 1987

LIMBI STRĂINE CUNOSCUTE:

-Engleza nivel C1 conform Cadrului Comun European de Referinţă (autoevaluare);

-Franceză nivel B2 conform Cadrului Comun European de Referinţă (autoevaluare).

EVOLUȚIE PROFESIONALĂ

-Medic stagiar in Spitalul Militar Central 1987-1990

-Medic secundar prin concurs specialitatea psihiatrie, Clinica Psihiatrie - Spitalul Prof.

Gh. Marinescu - Bucuresti 1990

-Medic specialist psihiatru, 1994

-Participant la misiunea “Restore Hope”, Somalia, 1994

-Medic primar psihiatru 1998

-Doctor in științe medicale, 2001 (U.M.F. Carol Davila, București), coordonator Acad.

Prof. Dr. Victor Voicu;

-Lector sub egida European Addiction Training Institute, Amsterdam : « New

approaches in Drug and Alcohol Dependence Treatment », 2002

-Invited speaker la 7th

Regional Meeting of European College of

Neuropsychopharmacology, 2002

-Membru in Comisia de sustinere a concursului de specialitate, disciplina Psihiatrie,

2002

-Coordonator de centru de studii în cadrul studiului EUFEST (European First Episode

of Schizophrenia) desfăşurat sub egida Uniunii Europene.

-Șef de lucrări, UMF Carol Davila Bucuresti, 2003

-Șef al Secției Psihiatrie din cadrul Spitalului Clinic de Urgenta Militar Central „Carol

Davila”, Bucuresti, iulie 2007

-Absolvent al programului de Master în domeniul Managementului Sistemului de

Sănătate la Universitatea București, cu durata de două semestre (2008);

-Conferențiar universitar Psihofarmacologie Clinica UMF Carol Davila Bucuresti, mai

2009

-Investigator principal și subinvestigator din anul 2000 în studii clinice multicentrice

de fază IIa, IIb, III și IV, axate pe patologii precum schizophrenia, tulburarea schizoafectivă,

tulburarea depresivă majoră, tulburarea afectivă bipolară, demența Alzheimer, demența

fronto-temporală etc.;

-Coordonator de formare profesională a rezidenților în specialitatea Psihiatrie în cadrul

Secției Clinice Psihiatrie a Spitalului Universitar de Urgență Militar Central Dr. Carol Davila.

CARȚI PUBLICATE

D. Vasile , M.D. Gheorghe, V. Voicu. Dependenţa de heroină. Editura Medicală Amaltea,

2001; ISBN 973-9397-28-X

2

D.Vasile. Mit şi realitate în mecanismul dependenţei la benzodiazepine. Editura

Medicală Amaltea Bucureşti, 2003; ISBN 973-9397-59-X.

D. Vasile, O.Vasiliu. Abordări terapeutice cognitiv-comportamentale în cazurile de dublu

diagnostic depresie- tulburări de personalitate. Editura Printech, Bucureşti, 2007; ISBN 978-

973-718-720-8

D.Vasile, O.Vasiliu. Terapia farmacologică a tulburărilor anxioase. Curs. Editura Printech,

Bucureşti, 2008; ISBN 978-606-521-052-3

D.Vasile, O.Vasiliu. Evaluarea şi managementul riscului suicidar în tulburările de

personalitate. Editura Printech, 2008; ISBN 978-606-521-061-5

D.Vasile, O.Vasiliu. Abordări terapeutice în dependenţa de substanţe. Editura Printech, 2009;

ISBN 978-606-521-200-8

D.Vasile, O.Vasiliu. Factori de vulnerabilitate în toxicomanii. Editura Printech, 2009; ISBN

978-606-521-201-5

Cărți publicate de la ultima promovare:

D.Vasile, O.Vasiliu. Psihopatologie generală-vol.1. Semiologie. Editura Printech, 2009; ISBN

978-606-521-356-2

D.Vasile, O.Vasiliu. Psihopatologie generală-vol.2. Sindromologie. Editura Printech, 2009;

ISBN 978-606-521-357-9

D.Vasile, O.Vasiliu. Factorii compliantei terapeutice in psihiatrie. Ed. Printech, 2009; ISBN

978-606-521-370-8

D.Vasile, O.Vasiliu. Psihofarmacologie clinică interactivă. Teste comentate. Ed. Printech,

București, 2013; ISBN 978-606-23-0099-9

CAPITOLE DIN MONOGRAFII

Actualităţi în psihiatria biologică

Editura Intact, 1999.

Coautor la capitolul „Suicidul –o placă turnantă a psihiatriei moderne”

The Role of the Muscarinic Receptors and of the Nitric Oxide in the Morphinic

Withdrawal

Glissando Ed. Iasi, 2001

D.Vasile, M.D.Gheorghe In: „Pharmacodependences Mechanism Clinical Aspects,

Treatment”

Semiologie si sindromologie psihiatrica

Editura Universitatii « Carol Davila », 2002

coautor la capitolul « Semiologie psihiatrica orientativa »

Aspecte bioetice ale abordării pacientului în psihooncologie

O.Vasiliu, D.Vasile

în „Standarde europene pentru programe postdoctorale competitive de formare în

domeniul managementului cercetării avansate şi expertizei psihiatrice medico-legale”,

IML Iaşi, Ed.Timpul, Iaşi, 2013

3

GRANTURI ȘI PROIECTE EDUCATIONALE

Proiecte internaționale de cercetare - Central Eastern Europe representative și

responsabil național în următoarele studii clinice:

-A study of RO4917838 in patients with sub-optimally controlled symptoms of schizophrenia

(NN25307). Phase 3, 2010.

-A study of RO4917838 in patients with persistent, predominant negative symptoms of

schizophrenia (NN25310). Phase 3, 2010.

Proiecte internaționale de cercetare- responsabil:

-A study of GWP42003 as adjunctive therapy in the first line treatment of schizophrenia or

related psychotic disorder. Sponsor GW Research LTD. Phase 2 study, placebo controlled.

2013.

-A multicenter, inpatient and ambulatory, phase 2, double-blind, randomized, placebo-

controlled, proof of concept study of CYR-101 in patients with DSM-IV schizophrenia.

Proiecte internaționale de cercetare- membru:

European First Episode of Schizophrenia Trial (EUFEST), 2002-2006

Proiecte educaționale:

Introducere în psihofarmacologie clinică- partea 1, coordonator conf.univ.dr. Daniel Vasile,

24.03.2015, Sponsor Johnson&Johnson

Enseignement postuniversitaire de psychooncologie (coord. Prof.dr. J.Fr. Allilaire si Prof.dr.

I. Popescu)- Bucuresti, 2002- 2003, speaker invitat

Actualități clinice și farmacologice în depresia majoră (4 și 11 noiembrie 2008) organizat de

Liga de Sănătate Mentală, 175 de medici participanți, director de proiect

"New approaches in drug and alcohol addiction" coordinated by European Addiction Training

Institute, lecturer

Granturi de cercetare naționale- membru în echipa de cercetare:

PNCDI II nr.41035/2007 “Evaluarea polimorfismului genetic ca sursă a variabilității

răspunsului terapeutic la medicantele cu metaboliți activi” (POLIGENACT), perioada 2007-

2010

PNCDI II nr.41049/2007 ”Impactul farmacocinetic și clinic al factorilor neuroendocrini în

terapia cu antipsihotice atipice” (HORMONANTIPSI), perioada 2008-2011

PNCD II nr.41053/2007 ”Dezvoltarea investigației farmacogenetice pentru personalizarea

terapiei medicamentoase în boala cardiovasculară” (FARMACOGENOMCCV), perioada

2007-2010

CURSURI POSTUNIVERSITARE DE PERFECȚIONARE ÎN ȚARĂ:

1. U.M.F. « Carol Davila » Bucuresti ; specializarea Neurologie- Urgențe neurologice :

diagnostic clinic si tratament, 1998

2. U.M.F. « Carol Davila » Bucuresti ; specializarea Psihiatrie-Urgențe psihiatrice :

diagnostic clinic si tratament, 1998

3. Centrul de Perfectionare Postuniversitara a Medicilor si Farmaciștilor- S.M.C.

Bucuresti- : Strategii terapeutice actuale in practica psihiatrica, 1999

4. Centrul de Perfectionare Postuniversitara a Medicilor si Farmacistilor- S.M.C.

Bucuresti-Introducere in neurochimia psihiatrica, 1999

5. Centrul de Politici si Servicii de Sanatate, in colaborare cu Open Society Institute New

York- Sinaia- : « Implementing Effective Drug Substitution Therapy in

Romania »,2000

6. Enseignement postuniversitaire de psychooncologie (coord. Prof.dr. J.Fr. Allilaire si

Prof.dr. I. Popescu)- Bucuresti, 2002- 2003

4

7. Managementul sistemului de sănătate. Masterat la Universitatea Bucureşti,

Facultatea de Sociologie şi Asistenţă Socială, 2009

8. Managementul serviciilor de sănătate, Şcoala Naţională de Sănătate Publică şi

Management Sanitar, 2010

9. Standarde europene pentru programe postdoctorale competitive de formare în

domeniul managementului cercetării avansate şi expertizei psihiatrice medico-legale”,

program desfăşurat de Centrul de Cercetare Avansată Bucureşti, în perioada ianuarie-

iunie 2011

10. Standarde europene pentru programe postdoctorale competitive de formare în

domeniul managementului cercetării avansate şi expertizei psihiatrice medico-legale,

program desfăşurat de Centrul de Cercetare Avansată Iasi, în perioada aprilie 2012-

aprilie 2013.

CURSURI POSTUNIVERSITARE DE PERFECȚIONARE ÎN STRĂINĂTATE :

1. Reseau Ville- Hopital Toxicomanies de Lyon, France : Stage complete sur le dispositif

specifique de prise en charge des personnes presentant une pharmacodependance, 2000

2. Centre Hộspitalier Universitaire Brugmann, Bruxelles, Belgium-Stage dans la Clinique d’

Alcoologie et des Toxicomanies, 2000

3. Centre Medical Enaden, Bruxelles, Belgium-Toxicomanies- Alcool, drogues,

Medicaments, 2000

4. European Addiction Training Institute- Antwerp, Belgium : « Techniques of Relapse

Prevention of Addictive Behaviours », 2001

5. Hộspital Erasme, Bruxelles, Belgium- Stage de formation dans le service de psychiatrie et

au Laboratoire du sommeil conduit par le Professeur Julien Mendlewicz,2001

6. Jellinek Centre and the European Addiction Training Institute, Amsterdam, Holland :

Program with experts of the Jellinek, 2001

7. Université Libre de Bruxelles- Centre Hospitalier Universitaire Brugmann, Bruxelles,

Belgium-Psychoses et troubles de l’humeur, 2001

8. Institut de Psychiatrie et de Psychologie Medicale Bruxelles, Belgium: Techniques

d’electrophysiologie diagnostique adaptée aux patients psychiatriques, 2001

9. Unitas de conduitas addictivas, Valencia, Espana : Los tratamientos para los addictivos,

2002

10. Hospital Universitario de San Juan, Alicante, Espana : Programa DRAO en el Servicio de

Medicina Intensiva, 2002

CERCETĂRI FARMACOCLINICE

Investigator principal în 30 de studii multicentrice internaționale de fază IIa, IIb și III

axate pe terapia schizofreniei, tulburării schizoafective, depresiei majore, demenței

Alzheimer, demenței fronto-temporale, tulburării bipolare.

PARTICIPĂRI LA MANIFESTĂRI ȘTIINȚIFICE NAȚIONALE ȘI

INTERNAȚIONALE

1. 17 th

Danube Symposium of Psychiatry, Timişoara-Romania, 24-27 Aprilie, 1996

2. 1st Congress of Balkan Military Medical Committee, Istanbul-Turcia, 6-8 Mai, 1996

3. International Conference on Suicide: Biopsychosocial Approaches Atena-Grecia,

16-19 Mai, 1996

4. IVth Salon International Psy & SNC, Paris-Franţa, 15-19 Octombrie, 1996

5. 2nd Congress of the Balkan Military Medical Committee, Sofia-Bulgaria, 6-9

Octombrie, 1997

6. 4th Congress of the Balkan Military Medical Committee Bucarest, 6-9 June, 1999

7. XXth

Congress of the International Association for Suicide Prevention, 6-10 Nov.,

Athens-Greece,1999

5

8. 5th

Congress of Balkan Military Medical Comitee, Ankara-Turkey, 25-28

Sept., 2000

9. Implementing Effective Drug Substitution Therapy in Romania, 18-21 sept. 2000

Sinaia, simpozion organizat de Open Society Institute New York and Center for Health

Policies and Services

10. 10 th

Association of European Psychiatrists Congress, Praga 28 Oct-1 Nov, 2000

11. Alzheimer Europe 11th

Conference June 10-12, 2001, Bucharest, Romania

12. 7th

World Congress Biological Psychiatry 1-6 July 2001 Berlin, Germany

13. 7th Regional Meeting of European College of Neuropsychopharmacology,

Bucharest,19-21 Aprilie 2002

14. 5th Xenobiotic Metabolism and Toxicity Workshop of Balkan Countries,

Constanta, 29mai-01iun.2002

15. 3th Regional Meeting: Financing Mintal and Addictive Disorders in Central and

Eastern Europe, Bucharest, 23-25.11.2001

16. 15th Congress of the European College of Neuropsychopharmacology, Barcelona,

Spain, October 5-9, 2002

17. 3rd Conference of International Early Psychosis Association, Copenhagen,

Denmark, 24-28 September, 2002.

18. „Global Adivsory Forum – Risperdal Consta”, Cannes - Franţa, 9-10 November,

2003

19. AEP Spring Symposium „Memories”, Roma - Italia, 24 –26 april, 2003

21. 8th Congress of BMMC, Cluj,2003

22. Forumul de psihiatrie, 2004.

23. 12th WPA International Congress, Florenta, nov. 2004

24. 17th ECNP Congress, Stockholm, oct.2004

25. International Congress of Biological Psychiatry, Sydney, feb. 2004

26. Conferinta Nationala de Terapie si Management in Psihiatrie, sept.-oct. 2004,

Craiova

27. Forumul de Psihiatrie 2005

28. 8th World Congress of Biological Psychiatry,Vienna, jul 2005

29. 13 th WPA International Congress, Cairo, 10-15 sept 2005

30. Students and Young Doctors 1st European Congress of Military Medicine,

Bucharest, oct. 2005

31. 18th ECNP Congress, Amsterdam, 22-26 oct. 2005

32. 11th Congress of Balcan Military Committee, Athens, june 18-22, 2006

33. 19th ECNP Congress, 16-20 sep 2006, Paris

34. 15th

European Congress of Psychiatry, Madrid, Spain, March 17-21, 2007.

35. American Psychiatric Association 160th Annual Meeting „Addressing Patient

Needs: Access, Parity and Human Care”, San Diego, may 19-24, 2007

36. 39th International Danube Symposium for Neurological Sciences and Continuing

Education in conjunction with the 1st International Congress on ADHD from childhood to

adult disease, 2-5 june 2007, Wurzburg

37. Forumul de Psihiatrie 2007, Bucuresti, 21-23 iunie 2007

38. '8th International Psychiatry Forum - Mind Matters Organised by sanofi-aventis'

Bucharest, 22-23 June 2007 Bucharest.

39. 12th Congress of BMMC, 24-28 iunie 2007, Poiana Brasov

40. The 20th

ECNP Congress, 13-17 oct 2007, Vienna, Austria

41. Astra Zeneca Neuroscience Academy 16-18 nov 2007, Bruxelles

42. An international meeting of minds supported by AstraZeneca Meet-the-Expert

Workshop, 3-5 March 2008 Athens, Greece

43. American Psychiatric Association 161st Annual Meeting, Washington, 03-08 may

2008

44. 13th Congress of BMMC, 1-5 june 2008, Kusadasi

45. XXVI CINP Congress, 13-17 july, Munich, Germany

46. 12th EFNS Congress, Madrid, Spain, 23-26 aug, 2008

6

47. 21’st Congress of the European College of Neuropsychopharmacology, 30

aug – 03 sep 2008, Barcelona, Spain

48. XIV World Congress of Psychiatry, 20-25 sep 2008, Praga

49. „Living with bipolar disorder: symptom control and beyond” – an international

meeting of minds sponsored by AstraZeneca Neuroscience, 27-29april 2009, Stockholm,

Suedia

50. American Psychiatric Association 162nd Annual Meeting, „Shaping our future:

science and service”, San Francisco 16-21 may 2009

51. 9th World Congress of Biological Psychiatry, 28 june-2 july 2009, Paris, France.

52. Simpozionul regional „Optiuni terapeutice actuale in tratamentul schizofreniei si al

depresiei”, Bucuresti, 10, 16 iulie 2009

53. „Preceptorship Programme on Alzheimer’s Disease”, Alzheimer Center at the VU

University Medical Center, 6 nov 2009 Amsterdam, Netherlands

54. 23rd ECNP Congress, 28 August-01 September 2010, Amsterdam, Netherlands

55. Recent Advances in Risk Management, Assessment and Mitigation, 2010,

București

56. 19th

European Congress of Psychiatry, 12-15 March, Vienna, Austria

57. 26th

ECNP Congress, 5-9 October 2013, Barcelona, Spain

58. 21st European Congress of Psychiatry, 6-9 April 2013, Nice, France

59. 27th

ECNP Congress, 18-21 October 2014, Berlin, Germany

60. 23rd

European Congress of Psychiatry, 28-31 March 2015, Vienna, Austria

61. 24th

European Congress of Psychiatry, 12-15 March 2016, Madrid, Spain

62. 29th

ECNP Congress, 17-20 September 2016, Vienna, Austria

LUCRĂRI IN-EXTENSO COTATE ISI

1. Vasile D, Vasiliu O. Management of affective symptoms and quality of life improvement

after primary brain tumor surgery. North Atlantic University Union Proceedings of the World

Medical Conference, 2010, 276-278

2. D.Vasile. Harm-reduction as risk decreasing strategy in heroin dependence. North Atlantic

University Union Proceedings of the World Medical Conference, 2010, 294-296.

3. Vasile D, Vasiliu O. Anticonvulsants for severe behavioral disturbances in Alzheimer

dementia. North Atlantic University Union Proceedings of the World Medical Conference,

2010, 279-283

4. Vasile D, Vasiliu O. Management of Cognitive symptoms in dementia associated with

Parkinson’s disease. North Atlantic University Union Proceedings of the World Medical

Conference, 2010, 284-286

5. Vasile D, Vasiliu O. Matching Psychotropics to Neurobiological Mechanisms in the

Aftermath of a Traumatic Event: A Literature Review. North Atlantic University Union

Proceedings of the World Medical Conference, 2010, 287-293.

6. Landolt K, Rossler W, Ajdacic-Gross V, Derks EM, Libiger J, Kahn RS, Fleischhacker

WW, EUFEST Study Group (Vasile D et al). Predictors of discontinuation of antipsychotic

medication and subsequent outcomes in the European First Episode Schizophrenia Trials

(EUFEST). Schizophr Res 2016;172(1-3):145-51. doi:10.1016/j.schres.2016.01.046.

7. Rybakowski JK, Vansteelandt K, Remlinger-Molenda A, Fleishhacker WW, Kahn RS,

Peuskens J, EUFEST Study Group (Vasile D et al). Extrapyramidal symptoms during

treatment of first schizophrenia episode. Eur Neuropsychopharmacol 2014;24(9):1500-5.

doi:10.1016/j.euroneuro.2014.07.001.

7

8. Riecher-Rossler A, Rybakowski JK, Pflueger MO, Beyrau R, Kahn RS, Malik P,

Fleischhacker WW, EUFEST Study Group (Vasile D et al). Hyperprolactinemia in

antipsychotic-naïve patients with first-episode psychosis. Psychol Med 2013;43(12):2571-82.

doi:10.1017/S0033291713000226.

9. Wobrock T, Falkai P, Schmeider-Axmann T, Hasan A, Galderisi S, Davidson M, Kahn RS,

Derks EM, Boter H, Rybakowski JK, Libiger J, Dollfus S, Lopez-Ibor JJ, Peuskens J, Hranov

LG, Gaebel W, Fleischhacker WW, EUFEST study group (Vasile D et al). Comorbid

substance abuse in first-episode schizophrenia: effects on cognition and psychopathology in

the EUFEST study. Schizophr Res 2013; 147(1):132-9. doi:10.1016/j.schres.2013.03.001.

10. Czobor P, Volavka J, Derks EM, Bitter I, Libiger J, Kahn RS, Fleischhacker WW,

EUFEST Study group (Vasile D et al). Insight and hostility as predictors and correlates of

non-adherence in the European First Episode Schizophrenia Trial. J Clin Psychopharmacol

2013; 33(2):258-61. Doi:10.1097/JCP.0b013e3182856886.

11. Fleischhacker WW, Siu CO, Boden R, Pappadopulos E, Karayal ON, Kahn RS, EUFEST

Study Group (Vasile D et al). Metabolic risk factors in first-episode schizophrenia: baseline

prevalence and course analysed from the European First-Episode Schizophrenia Trial. Int J

Neuropsychopharmacol 2013;16(5):987-95. doi: 10.1017/S1461145712001241.

12. Galderisi S, Mucci A, Bitter I, Libiger J, Bucci P, Fleischhacker WW, Kahn RS, EUFEST

Study Group (Vasile D et al). Persistent negative symptoms in first episode with

schizophrenia: results from the European First Episode Schizophrenia Trial. Eur

Neuropsychopharmacol 2013;23(3):196-204. doi: 10.1016/j.euroneuro.2012.04.019.

13. Rybakowski JK, Vansteelandt K, Szafranski T, Thys E, Jarema M, Wolfgang

Fleishhacker W, Kahn RS, Peuskens J, EUFEST Study Group (Vasile D et al). Treatment of

depression in first episode of schizophrenia: results from EUFEST. Eur

Neuropsychopharmacol 2012;22(12):875-82. doi:10.1016/j.euroneuro.2012.04.001.

14. Landolt K, Rossler W, Burns T, Ajdacic-Gross V, Galderisi S, Libiger J, Naber D, Derks

EM, Kahn RS, Fleischhacker WW, EUFEST Study Group (Vasile D et al). Unmet needs in

patients with first-episode schizophrenia: a longitudinal perspective. Psychol Med

2012;42(7):1461-73. doi:10.1017/S0033291711002406.

15. Volavka J, Czobor P, Derks EM, Bitter I, Libiger J, Kahn RS, Fleischhacker WW,

EUFEST Study Group (Vasile D et al). Efficacy of antipsychotic drugs against hostility in the

European First-Episode Schizophrenia Trial (EUFEST). J Clin Psychiatry 2011;72(7):995-61.

doi:10.4088/JCP.10m06529.

16. Malik P, Kemmler G, Hummer M, Riecher-Roessler A, Kahn RS, Fleischhacker WW,

EUFEST Study Group (Vasile D et al). Sexual dysfunction in first-episode schizophrenia patients results from European First Episode Schizophrenia Trial. J Clin Psychopharmacol

2011;31(3):274-80. Doi:10.1097/JCP.0b013e3182199bcc.

17. Derks EM, Fleischhacker WW, Boter H, Peuskens J, Kahn RS, EUFEST Study Group

(Vasile D et al). antipsychotic drug treatment in first-episode psychosis: should patients be

switched to a different antipsychotic drug after 2,4 or 6 weeks of non-response? J Clin

Psychopharmacol 2010;30(2):176-80. doi: 10.1097/JCP.0b013e3181d2193c. 25 citări

18. Gaebel W, Riesbeck M, von Wilmsdorff M, Burns T, Derks EM, Kahn RS, Rossler W,

Fleischhacker WW, EUFEST Study Group (Vasile D et al). Drug attitude as predictor for

effectiveness in first-episode schizophrenia: Results of an open randomized trial (EUFEST).

Eur Neuropsychopharmacol 2010;20(5):310-6. doi:10.1016/j.euroneuro.2010.02.001.

8

19. Boter H, Derks EM, Fleischhacker WW, Davidson M, Kahn RS, EUFEST Study Group

(Vasile D et al). Generalizability of the results of efficacy trials in first-episode schizophrenia:

comparison between subgroups of participants of the European First Episode Schizophrenia

Trial (EUFEST). J Clin Psychiatry 2010;71(1):58-65. doi:10.4088/JCP.08m04506yel.

20. Boter H, Peuskens J, libiger J, Fleischhacker WW, Davidson M, Galderisi S, Kahn RS,

EUFEST Study Group (Vasile D et al). Effectiveness of antipsychotics in first-episode

schizophrenia and schizophreniform disorder on response and remission: an open randomized

clinical trial (EUFEST). Schziophr Res 2009;115(2-3):97-103.

doi:10.1016/j.schres.2009.09.019.

21. Kahn RS, Fleischhacker WW, Boter H, Davidson M, Vergouwe Y, Keet IP, Gheorghe

MD, Rybakowski JK, Galderisi S, Libiger J, Hummer M, Dollfus S, Lopez-Ibor JJ, Hranov

LG, Gaebel W, Peuskens J, Lindefors N, Riecher-Rossler A, Grobbee DE, EUFEST Study

Group (Vasile D et al). Effectiveness of antipsychotic drugs in first-episode schizophrenia and

schizophreniform disorder: an open randomised clinical trial. Lancet 2008;371(9618):1085-

97. doi:10.1016/S0140-6736(08)60486-9.

22. Dima L, Vasile D, Rogozea L, Zia-Ul-Haq M, Bukhari SA, Moga M. Self-perception of

quality of life in patients treated with antipsychotics. Turk J Med Sci 2015;45(4):782-8.

23. Heun R, Ahokas A, Boyer P, Gimenez-Montesinos N, Pontes-Soares F, Olivier V,

Agomelatine Study Group (Vasile D et al). The efficacy of agomelatine in elderly patients

with recurrent major depressive disorder: a placebo-controlled study. J Clin Psychiatry

2013;74(6):587-94. doi:10.4088/JCP.12m08250.

24. Vasile D. Harm-reduction as risk decreasing strategy in heroin dependence. North

Atlantic University Union Proceedings of the World Medical Conference, 2010, 16.

25. Anand R, Geffen Y, Vasile D, Dan I. An open-label tolerability study of BL-1020

antipsychotic: a novel gamma aminobutyric acid ester of perphenazine. Clin

Neuropsychopharmacol 2010;33(6):297-302. Doi: 10.1097/WNF.0b013e3181f8d501.

STUDII PUBLICATE ÎN REZUMAT COTATE ISI

1. Early pharmacological intervention in first episode schizophrenia

Abstracts of the 7th

Regional Meeting of ECNP

European Neuropsychopharmacology 2002;12(Suppl.2):S34-S35

Vasile D

2. Reboxetine in the treatment of elderly inpatients with Major Depressive Disorder



European Neuropsychopharmacology 2002;12(Suppl.2):S41

Vasile D, Vasiliu O, Baloescu A, Grigorescu G, Gheorghe MD

3. Efficacy of venlafaxine in the treatment of generalized anxiety disorder



European Neuropsychopharmacology 2002;12(Suppl.2):S56-57

Vasile D, Ciurea R, Baloescu A

4. Efficacy of Rivastigmine on cognitive and behavioural symptoms in patients with

Alzheimer’s disease



9


Baloescu A, Tudor C, Vasile D, Ciurea R, Gheorghe MD

5. Heroin-consuming relapse after detoxification Abstracts of the 7

th Regional Meeting of ECNP


Vasile D, Ciurea R, Gheorghe MD

6. The efficacy of donepezil in Alzheimer’s disease cognitive deficit Abstracts of the 7



Vasile D, Gheorghe MD

7. The effects of adenosinic agonists and antagonists on behaviour and on EEG activity

in rats



European Neuropsychopharmacoclogy 2002;12(Suppl.3):S438

Cristescu I, Raducanu T, Zugravu A, Vasile D, Stoleru S

8. Antisocial personality disorder-heroin dependence comorbidity Abstracts of the 7


European Neuropsychopharmacoclogy 2002;12(Suppl.3):S392

Vasile D, Gheorghe MD, Ciurea R, Paraschiv S

9. Efficacy of reboxetine and amisulpride on cognitive functions in elderly inpatients

with major depressive disorder and psychotic features

16th Congress of the European College of Neuropsychopharmacology

European Neuropsychopharmacology 2003;13(Suppl.4):S229-230.

Vasile D, Ciurea R, Gheorghe MD

10. Analgesic effect of trazodone in neoplasm associated pain.

European Psychiatry 2004;19 (Suppl.1):233S.

Vasile D, Gheorghe M, Vasiliu O.

11. The efficacy of amisulpride on negative symptoms in chronic schizophrenia.

24th

CINP Congress

International Journal of Neuropsychopharmacology 2004;7(Suppl.1):S410.

Vasile D, Gheorghe M, Vasiliu O, Paraschiv SL

12. Side effects of atypical antipsychotics in first episode of schizophrenia in young

males.

4th

International Conference on Early Psychosis

Schizophrenia Research 2004;70(1, Supplement):145

Vasile D, Gheorghe MD, Vasiliu O, Apetroaei A, Paraschiv S

13. Clinical course features in first episode schizophrenia in young male.

4th

International Conference on Early Psychosis

Schizophrenia Research 2004;70(1, Supplement):113

Vasile D, Gheorghe MD, Vasiliu O, Apetroaei A, Paraschiv S

14. Drug monitoring factors in schizophrenia treatment.

17th

ECNP Congress.


Vasile D, Gheorghe M.D, Vasiliu O, Paraschiv S.

10

15. Sexual dysfunctions in patients with depression treated with SSRI: A therapeutic

approach

12th AEP Congress

European Psychiatry 2004;19(Suppl.1):215S

Vasile D, Gheorghe M, Vasiliu O

16. Quality of life assessment in Alzheimer disease

European Psychiatry 2005;20(Suppl.1):S6

Vasile D, Gheorghe M

17. Psychopathological and somatic comorbidity in major depressive disorders.

European Psychiatry 2005;20 (Suppl.1):S147.

Vasile D, Gheorghe M, Vasiliu O, Lungut E

18. The efficacy of bupropion in alcohol dependent patients with major depressive

episode

18th ECNP Congress

European Neuropsychopharmacology 2005;15(Suppl.3):S400.

Vasile D, Gheorghe MD, Vasiliu O

19. Parenteral administration of olanzapine for schizophrenic with agressive behaviour

18th ECNP Congress


Vasile D, Gheorghe MD, Vasiliu O, Baloescu A

20. Antidepressant switch efficacy in SSRI resistant major depressive disorder.

19th

ECNP Congress

European Neuropsychopharmacology 2006;16(4):S324

Vasiliu O, Vasile D, Miclos M, Ivanov P

21. Amisulpride association to SSRI in severe major depressive episodes with psychotic

features.

19th

ECNP Congress.


Vasiliu O, Vasile D, Paraschiv S, Miclos M, Ivanov P

22. Bupropion efficacy in major depressive disorder and alcohol dependence dual

diagnosis

19th ECNP Congress


Vasile D, Sarmache M, Vasile ML, Gheorghe MD

23. Risperidone long acting im formulation in high risk of noncompliance bipolar

patients

19th ECNP Congress


Vasile D, Vasiliu O, Ojog D, Gheorghe MD

24. Negative and cognitive syptomatology improvement during aripiprazole treatment

in chronic schizophrenia

19th ECNP Congress


Gheorghe MD, Voicu VA, Vasile D, Vasiliu O

11

25. Side effects of atypical antipsychotics – prediction for factor for compliance

19th ECNP Congress


Baloescu A, Vasile D, Gheorghe MD, Grigorescu G

26. Augmenting psychopharmacological treatment with cognitive behavioural therapy

in major depressive disorder with alcohol dependence dual diagnosis. DP-02-02.

39th

International Danube Symposium for Neurological Sciences and Continuing Education in

conjunction with the 1st International Congress on ADHD from childhood to adult disease, 2-

5 June 2007, Wurzburg.

Journal of Neural Transmission 2007;114(7):CXIX

Vasile D, Vasiliu O, Sarmache M, Terpan M, Ojog D

27. Intramuscular olanzapine efficiency in the accute treatment of schizoaffective

disorder. DP-02-04.

39th

International Danube Symposium for Neurological Sciences and Continuing Education in

conjunction with the 1st International Congress on ADHD from childhood to adult disease, 2-

5 June 2007, Wurzburg.

Journal of Neural Transmission 2007;114(7):CXIX

Vasile D, Vasiliu O, Paraschiv S, Vasile M, Brisculescu R.

28. Metabolic adverse events of antipsychotic treatment in chronic schizophrenia

Vasile D, Vasiliu O, Paraschiv S, Ivanov P, Terpan M, Vasile M

29. Venlafaxine XR versus fluoxetine in the treatment of major depressive disorder and

generalized anxiety disorder dual diagnosis 15th AEP Congress

European Psychiatry 2007;22(Suppl.1): S247

Vasile D, Vasiliu O, Ivanov P, Ojog D, Sarmache M, Vasile M

30. Augmenting antidepressant psychopharmacological approach with cognitive-

behavioural therapy in bipolar depression

15th AEP Congress


Vasile D, Vasiliu O, Ojog D, Vasile M, Sarmache M, Terpan M

31. Nonbenzodiazepine versus benzodiazepine hypnotic eficiency in older people

15th AEP Congress


Vasile D, Vasiliu O, Vasile M, Sarmache M, Terpan M

32. Intramuscular and orodispersable olanzapine efficiency in the acute treatment of

manic episodes

20th ECNP Congress


Vasile D, Vasiliu O, Paraschiv S, Vasile M, Terpan M

33. Combined atypical antipsychotics and valproate sodium approach in the bipolar I

disorder maintenance treatment

20th ECNP Congress


Vasile D, Vasiliu O, Miclos M, Ivanov P, Sarmache M

12

34. Combined antidepressants and quetiapine therapy in bipolar depression with

psychotic features- an open label study

20th ECNP Congress


Vasile D, Vasiliu O, Paraschiv S, Ojog D, Vasile M

35. Combined pregabalin and selective serotonin reuptake inhibitors in adjustement

disorders with anxiety

20th ECNP Congress


Vasile D, Vasiliu O, Ivanov P, Sarmache M, Terpan M

36. Alteration of body image perception as a side event of antipsychotic treatment in

schizophrenic patients

16th AEP European Congress of Psychiatry


Vasile D, Vasiliu O, Ivanov P, Terpan M, Paraico I

37. Improving the quality of life in patients with malignant tumors using cognitive

psychotherapy


European Psychiatry 2008;23(Suppl.2):S302-303

Vasile D, Vasiliu O, Vasile M, Sarmache M

38. Coping mechanisms evaluation in chronic schizophrenic patients



Vasile D, Vasiliu O, Vasile M, Terpan M, Paraico I

39. Alzheimer dementia associated cognitive and non-cognitive symptoms evolution

during donepezil treatment



Vasile D, Vasiliu O

40. Cognitive-behavioral therapy efficacy in major depressive disorder and histrionic

personality disorder dual diagnosis



Vasile D, Vasiliu O, Ojog D, Brisculescu R, Vasile M

41. Oral risperidone efficacy in Alzheimer dementia with psychotic features

XXVI CINP Congress

The International Journal of Neuropsychopharmacology 2008;11(Suppl.1):176

Vasile D, Vasiliu O, Patriche D, Stanescu B, Bancescu R

42. Bupropion SR augmentation strategy in mirtazapine major depressive disorder

incomplete responders

XXVI CINP Congress


Vasile D, Vasiliu O, Vasile M, Cretu O, Ojog D

43. Serotoninergic combos in treatment resistant depressive disorder

XXVI CINP Congress

13

The International Journal of Neuropsychopharmacology 2008; 11

(Suppl.1):207

Vasile D, Vasiliu O, Vasile M, Cretu O, Terpan M

44. The switch on trazodone in major depressive disorder with significant weight gain

XXVI CINP Congress


Vasile D, Vasiliu O, Vasile M, Cretu O, Ojog D

45. The efficacy of venlafaxine vs. SSRIs in panic disorder and major depressive

disorder dual diagnosis

XXVI CINP Congress

The International Journal of Neuropsychopharmacology 2008;11(Suppl.1):284-285

Vasile D, Vasiliu O, Stanescu B, Bancescu R, Terpan M

46. Efficacy of tianeptine in the treatment of post-stroke depression

12th Congress of the European Federation of Neurological Societies

European Journal of Neurology 2008;15(Suppl.3):267

Vasile D, Vasiliu O, Cretu O, Patriche D, Stanescu B, Bancescu R

47. Therapeutic management of interictal dysphoria in epilepsy


European Journal of Neurology 2008;15(Suppl.3):425

Vasile D, Vasiliu O, Ivanov P, Stanescu B, Terpan M, Bancescu R

48. Atypical antipsychotics in the treatment of non-cognitive symptoms of Alzheimer

dementia


European Journal of Neurology 2008;15(Suppl.3):233-34

Vasile D, Vasiliu O, Ivanov P, Terpan M, Patriche D, Ojog D

49. An open study of the safety and efficacy of a novel antipsychotic (BL-1020) with

reduced risk for extrapyramidal symptoms

21st ECNP Congress


Anand R, Davidson M, Geffen Y, Vasile D, Dan I

50. Tolerability of rivastigmine transdermal patch in Alzheimer dementia with psychotic

features

22nd ECNP Congress.

European Neuropsychopharmacology 2009;19:S622-623.

Vasile D, Vasiliu O, Vasile M, Terpan M

51. Efficacy of trazodone in patients diagnosed with generalised anxiety disorder and

benzodiazepine dependence

22nd Congress of ECNP

European Neuropsychopharmacology 2009;19:S617-618

Zavoianu M, Luchian A, Tudor C, Grigorescu G, Vasile D

52. Ziprasidone switching effects on metabolic syndrome in patients treated with others

atypical antipsychotics

22nd Congress of ECNP

European Neuropsychopharmacology 2009;19:S495

Grigorescu R, Voicu V, Vasile D, Grigorescu G, Staicu M

14

53. Low doses risperidone in cluster A personality disorder- a prospective study.

XXVII CINP Congress

International Journal of Neuropsychopharmacology 2010;13:110

Vasile D, Vasiliu O, Terpan M, Vasile ML, Tudor C, Bogdan V, Mangalagiu AG, Grigorescu

G, Ojog D

54. Galantamine switch in donepezil non-responsive patients with early-onset Alzheimer

dementia

XXVII CINP Congress


Vasile D, Vasiliu O, Tudor C, Vasile ML, Grigorescu G, Bogdan V, Terpan M, Mangalagiu

AG, Petrescu MB, Ojog D.

55. Amisulpride augmentation vs. standard antidepressant therapy in major depressive

disorder.

XXVII CINP Congress.


Grigorescu G, Vasile D, Vasiliu O, Vasile ML, Tudor C, Cantemir A, Zavoianu M,

Mangalagiu AG, Terpan M, Grigorescu R.

56. Quality of life improvement through depression treatment in oncologic patients

18th European Congress of Psychiatry

European Psychiatry 2010;25(Suppl.1):997

Vasile D, Vasiliu O, Vasile ML, Mangalagiu AG, Stanescu B, Petrescu BM, Nastase DM,

Bogdan V

57. The efficacy of psychopharmacologic treatment in depressive disorder associated

with Parkinson’s disease dementia



Vasile D, Vasiliu O, Bogdan V, Badescu E, Mangalagiu AG, Stanescu B, Petrescu BM

58. The influence of the conflicting paradigms over the prognosis in major depressive

disorder



Vasile D, Vasiliu O, Vasile ML, Mangalagiu AG, Badescu E, Petrescu BM, Bogdan V, Ojog

D

59. Treatment strategies for the management of the self-agressive manifestations in

heroin dependence



Vasile D, Vasiliu O, Vasile ML, Mangalagiu AG, Stanescu B, Terpan M, Nastase DM,

Petrescu BM, Bogdan V

60. Addressing self-image distorsions as a core feature in the alcohol dependence

psychotherapeutic approach


European Psychiatry 2010;25(Suppl.1):1678.

Vasile D, Vasiliu O, Mangalagiu AG, Vasile ML, Badescu E, Bogdan V, Terpan M, Ojog

DG, Petrescu BM

61. Efficacy of milnacipran in patients with interferon-a2 induced depression

23rd Congress of ECNP


15

Zavoianu M, Cantemir A, Tudor C, Grigorescu G, Vasile D.

62. Influences between defense mechanisms and antidepressants on the therapeutic

compliance in major depressive disorder

23rd ECNP Congress

European Neuropsychopharmacology 2010;20:S343-S344

Vasile D, Vasiliu O, Vasile ML, Terpan M, Mangalagiu A, Bogdan V, Ojog D, Petrescu MB,

Paraico I

63. Comparative efficacy of cholinesterase inhibitors in dementia associated with

Parkinson’s disease

23rd ECNP Congress


Vasile D, Vasiliu O, Vasile ML, Terpan M, Grigorescu G, Bogdan V, Mangalagiu A,

Petrescu MB, Ojog D.

64. Standard antidepressant therapy vs association between amisulpride and

antidepressant theray in atypical depression

23rd ECNP Congress


Grigorescu G, Baloescu A, Vasile D, Tudor C, Vasiliu O, Grigorescu R

65. Agomelatine versus selective serotoninergic reuptake inhibitors in major depressive

disorder and comorbid diabetes mellitus.

24th Congress Meeting of ECNP

Vasile D, Vasiliu O, Vasile M.L, Terpan M, Ojog DG

European Neuropsychopharmacology 2011;21(Suppl.3):S383-384.

66. Efficacy and safety of duloxetine in patients with melancholic depression

24th Congress Meeting of ECNP


Tudor C, Cantemir A, Grigorescu G, Vasiliu O, Vasile D, Zavoianu M.

67. Cognitive behavioral therapy focused upon communicational skills enhancement in

anorexia nervosa- a case series

19th

European Congress of Psychiatry

European Psychiatry 2011;26 (Suppl.1):P02-144

Vasile D, Vasiliu O, Mangalagiu AG, Tudor C, Bogdan V, Paraico I

68. Valproate and cognitive therapy combined treatment efficacy in pathological

gambling

19th


European Psychiatry 2011;26(Suppl.1):P03-121

Vasile D, Vasiliu O, Vasile B, Tudor C, Mangalagiu AG, Ojog DG

69. Therapeutic efficacy of duloxetine versus selective serotonin reuptake inhibitors in

irritable bowel syndrome

19th



Vasile D, Vasiliu O, Tudor C, Bogdan V, Mangalagiu AG, Vasile ML, Terpan M

70. Incidence of axis I and II dual diagnosis in hospitalized patients with somatization

disorder

19th



16

Vasile D, Vasiliu O, Grigorescu G, Mangalagiu AG, Ojog DG, Bogdan V

71. Naltrexone efficacy in alcohol dependence with comorbid axis II diagnosis

European Psychiatry 2012;27(Suppl.1):P-101

Vasile D, Vasiliu O, Mangalagiu AG, Banica A, Stanescu B, Blandu M

72. Comparative analysis of dual serotonergic and noradrenergic antidepressants in

double depression with alcohol dependence


Vasile D, Vasiliu O, Mangalagiu AG, Banica A, Taina NF, Blandu M

73. Quality of life assessment in colon malignant tumors associated depression during

trazodone treatment


Vasile D, Vasiliu O, Mangalagiu AG, Blandu M, Banica A

74. Improvement of prognosis through long acting risperidone versus combined

adherence focused psychotherapy and oral antipsychotics in chronic schizophrenia.


Vasile D, Vasiliu O, Mangalagiu AG, Banica A, Taina NF, Stanescu B

75. Comparative analysis of agomelatine and trazodone in late-onset major depression

26th

ECNP Congress


D.Vasile, O.Vasiliu, C.Tudor, A.G. Mangalagiu, O.Magazin, G.A. Sopterean, R.E. Bratu

76. Pharmacological management of affective symptoms after primary hepatic tumor

surgery

International Journal of Neuropsychopharmacology 2012;15(Suppl.1):P-14-062

Vasile D, Vasiliu O, Mangalagiu AG, Nanca A

77. Comparative efficacy of cholinesterase inhibitors in dementia associated with



Vasile D, Vasiliu O, Mangalagiu AG, Blandu M, Nanca A

78. Quality of life assessment in fibromyalgia during duloxetine treatment


Vasile D, Vasiliu O, Mangalagiu AG, Blandu M, Nanca A

79. Naltrexone effectiveness in alcohol dependence with comorbid cluster B personality

disorders

International Journal of Neuropsychopharmacology 2012; 15 (Suppl.1):P-02-043

Vasile D, Vasiliu O, Blandu M, Ojog DG

80. A multicentric, retrospective data collection from patients diagnosed with

schizophrenia switched to amisulpride- SWITCH study

26th

ECNP Congress


D.Vasile, R.A. Macovei, O.Vasiliu, D.Ojog.

81. Evolution of addictive comorbidities in a group of patients diagnosed with

schizophrenia during atypical antipsychotic treatment

21st European Congress of Psychiatry

European Psychiatry 2013;28(1):1127

17

Vasile D, Macovei RA, Vasiliu O, Mangalagiu AG, Tudor C

82. The efficacy of social skills training over self-image distorsions in avoidant

personality disorder



Vasile D, Vasiliu O, Mangalagiu AG, Blandu M, Magazin O

83. Characteristics of the antipsychotic switch to amisulpride in schizophrenia in

Romanian practice- a multicentric, retrospective data collection (SWITCH study)



Vasile D, Vasiliu O, Mangalagiu AG, Petrescu BM

84. A multicentric, retrospective data collection from patients diagnosed with

schizophrenia switched to Solian ® in Romanian practice- SWITCH study

21st European Congress of Psychiatry.


Vasile D, Vasiliu O, Mangalagiu AG, Petrescu BM

85. Mirtazapine versus sertraline in the treatment of post-psychotic depression

26th

ECNP Congress


Vasile D, Vasiliu O, Sopterean GA, Bratu RE

86. Efficacy and tolerability of bupropion in major depressive disorder associated with


26th

ECNP Congress


Vasile D, Macovei RA, Vasiliu O

87. Pharmacological management of alcohol dependence in chronic schizophrenia

26th

ECNP Congress


Vasile D, Vasiliu O, Tudor C, Mangalagiu AG, Petrescu BM, Sopterean GA, Bratu RE

88. Comparative analysis of agomelatine and trazodone in late-onset major depression

26th

ECNP Congress


Vasile D, Vasiliu O, Tudor C, Mangalagiu AG, Magazin O, Sopterean GA, Bratu RE

89. Effectiveness and tolerability of nalmefene in alcohol use dependence comorbid with

schizophrenia.

27th ECNP Congress


Vasile D, Vasiliu O, Sopterean GA, Bratu RE, Androne F, Vasile F

90. Pharmacologic treatment strategies in premenstrual dysphoric disorder.

27th ECNP Congress


Vasile D, Macovei RA, Vasiliu O, Vasile F

91. Efficacy and tolerability of agomelatine switch in patients with sexual dysfunctions

treated with serotonin selective reuptake inhibitors

27th ECNP Congress

18


Vasile D, Macovei RA, Vasiliu O, Vasile F, Ojog DG

92. SSRI dose escalation versus duloxetine in treatment of major depressive disorder not

responding to initial SSRI

27th ECNP Congress

European Neuropsychopharmacology 2014;24(2):S455-456.

Petrescu B, Vasile D, Vasiliu O, Tudor C, Mangalagiu A, Ungureanu D

93. Comparative analysis of pregabalin and buspirone as adjunctive agents in major

depressive disorder partially responsive to SSRIs

27th ECNP Congress

European Neuropsychopharmacology 2014;24(2):S389.

Vasile D, Vasiliu O, Bratu RE, Sopterean GA, Vasile F, Ojog DG

94. Analysis of trazodone and pregabalin in neurocognitive disorders with psychomotor

agitation

23rd European Congress of Psychiatry

European Psychiatry 2015;30(Suppl.1):1464.

Vasile D, Vasiliu O, Bratu ER, Sopterean GA, Androne F, Vasile F

95. Affective symptoms as prognosis factor in schizophrenia

23rd European Congress of Psychiatry


Vasile D, Vasiliu O, Vasiliu DG, Vasile F

96. A comparative prospective study of agomelatine versus escitalopram in treatment of

severe major depressive disorder. P.2.f.009.

28th ECNP 2015. European

Neuropsychopharmacology 2015;25(Suppl.2):S439

Petrescu B, Vasile D, Vasiliu O, Mangalagiu AG, Tudor C, Ungureanu D

97. Assessment of suicide risk in schizophrenia with addictive comorbidity. EW567.

Abstracts of the 24th European Congress of Psychiatry

European Psychiatry 2016;33: S315


98. Assessment of sexual dysfunctions in depressive disorder. EV548.


European Psychiatry 2016;33: S525.


99. Assessment of eating disorders in patients diagnosed with major depressive disorder.

EV398.


European Psychiatry 2016;33: S475


100. Therapeutic management of obesity in patients who gained weight during

antidepressant treatment. P.2.h.003.

29th ECNP Congress


Vasile D, Vasiliu O, Bratu-Bazic RE, Androne FT, Patrascu M, Alboae AF, Moraru EA,

Candea C.

19

LUCRĂRI IN-EXTENSO COTATE BDI ȘI CNCSIS

1. Evaluãri multidimensionale prin imagisticã cerebralã în schizofrenie

M.D.Gheorghe, D. Vasile, Arina Baloescu, Gabriela Grigorescu

Revista de Medicinã Militarã, 1996;1:39-47

2. Serotonina - actualitãti în mediatia serotoninergicã - implicatii clinice si terapeutice

M.D.Gheorghe, Arina Baloescu, D. Vasile, R. Mihãitã

Revista de Medicinã Militarã, 1996;2:39-47

3. Interrelatii clinico-paraclinice in schizofrenia negativa M.D.Gheorghe, D. Vasile, A.Baloescu, G.Grigorescu

Revista de Medicina Militara, 1996;3:243-246

4. Migrena. Actualitati privind fiziopatologia si criteriile de diagnostic M.D.Gheorghe, E. Lungut, D. Vasile

Revista de Medicina Militara, 1996;4:325-333

5. Schizofrenia-Sindrom pozitiv si negativ (Noi dimensiuni clinico-terapeutice) M.D.Gheorghe, D.Vasile, A.Baloescu, G.Grigorescu

Medicina Moderna, 1996:III(6):293-295

6. Agenţii antipsihotici atipici – alternativă în tratamentul schizofreniei

D. Vasile

Revista de Toxicologie şi Terapeutică, 3, pg.191, 1998

7. Therapeutical profile in refractory depression

M.D.Gheorghe, D. Vasile, C. Andreescu, Gabriela Grigorescu

Balkan Military Medical Review, 1998;1(2):169-172.

8. Abordări terapeutice în sevrajul la opioide

D. Vasile, M. Stoenescu

Revista Durerea acută şi cronică, 2000;8(2):56

9. Sindromul de sevraj la opiacee. Toxicomania si sarcina

D. Vasile, M. Stoenescu, A.Vasilache

Revista de Medicina Militara, 2001;2 :239

10. Stimularea nervului vag – aplicatii in depresia refractara la tratament

D. Vasile, M.D.Gheorghe, R. Ciurea, C.Tudor

Revista Romana de Psihiatrie, 2001; III(1-2):49-53

11. Tratamentul farmacologic al dependentei de heroina

D. Vasile, M.D. Gheorghe, R. Ciurea, Corina Tudor

Revista Romana de Psihiatrie, 2001; III(3-4):170-174

12. Venlafaxina in tratamentul tulburarii de anxietate generalizata

D. Vasile, R. Ciurea

Revista de Terapeutica, Farmacologie si Toxicologie clinica, 2002;1:136

13. O noua abordare terapeutica in durerea cronica: mirtazapina

D. Vasile, M.R.Stoenescu

„Durerea”-Buletin informativ al Asociatiei Romane pentru Studiul Durerii, 2002;XII(1):11-13

20

14. Comparative Analysis of the Antipsychotics Side Effects in the Onset of

Schizophrenia in Conscripts.

D.Vasile, O.Vasiliu, S.Paraschiv, C.A.Sârbu, M.D.Gheorghe.

Balkan Military Medical Review 2002;5(1-2):24- 30

15. Efectul medicatiei psihotrope asupra intervalului QTc

D.Vasile, O.Vasiliu, S.Paraschiv, E. Lungut, A. Apetroaei

Terapeutică, Farmacologie şi Toxicologie Clinică 2004;VIII(2):115-118

16. Antidepresivele cu mecanism dual versus SSRI in terapia tulburarilor depresive

D.Vasile, M. Gheorghe, O.Vasiliu, A. Apetroaei

Jurnalul Roman de Psihofarmacologie, 2004; 4(1,2):25-31

17. Implicatiile neurobiologice si farmacoclinice ale efectului placebo D.Vasile, M.Gheorghe, A. Apetroaei, O.Vasiliu

Jurnalul Roman de Psihofarmacologie, 2004; 4(1,2):83-89

18. Factorii deciziei terapeutice- de la experienta clinica la studiile farmacologice D. Vasile, M.D.Gheorghe, O.Vasiliu, S.Paraschiv

Terapeutică, farmacologie şi toxicologie clinică 2004;VIII(4):63-66

19. Actualitati neurobiologice si farmacoclinice in dementa Alzheimer

D.Vasile, M.D.Gheorghe, O.Vasiliu, A.Apetroaei

Stetoscop 2005;38:42-43

20. Psychotropic Drugs Discontinuation Syndromes in Clinical Practice

D.Vasile, O.Vasiliu, M.Gheorghe, P.Ivanov, D.Ojog

Balkan Military Medical Review 2006;9:38-41

21. Terapia depresiei la pacienţii oncologici

D.Vasile, O.Vasiliu, O.Creţu, B.Stănescu, E.Bădescu, R.Băncescu, M.Terpan

Medicina Modernă 2008; XV(8):407-412

22. Actualităţi şi perspective în terapia farmacologică a tulburărilor de anxietate D.Vasile, O.Vasiliu, M.Vasile, D.Patriche, A.Bănică

Medicina Modernă 2008; XV(9):488-492

23. Evaluarea profilului terapeutic în adicţii

O.Vasiliu, D.Vasile, N.Mitrofan

Revista de Medicină Militară 2008;2:36-44.

24. Implicaţii clinice ale noilor mijloace de evaluare terapeutică în adicţii

O.Vasiliu, D.Vasile, N.Mitrofan

Revista de Medicină Militară 2008;2:51-61.

25. The role of N-Methyl-D-Aspartate receptors in the psychopharmacology of mood

disorders

D.Vasile, O.Vasiliu, M.Vasile, O.Creţu

Therapeutics Pharmacology and Clinical Toxicology 2008; XII(3):349-353.

26. Risperidone long acting administration in type I bipolar disorder noncompliant

patients.

D.Vasile, O.Vasiliu, D.Ojog.

Therapeutics, Pharmacology and Clinical Toxicology 2008; 4(XII):489-492.

21

27. Perturbările mnezice în tulburările psihice specifice.

D. Vasile, O. Vasiliu.

Revista de Medicină Militară 2008; 1:41-50

28. Evaluarea comorbiditatilor psihiatrice in tulburarile somatoforme

D.Vasile, O.Vasiliu

Revista de Medicină Militară 2008; 2:3-9.

29. Sindroame hepatotoxice asociate medicaţiei psihotrope.

D.Vasile, O.Vasiliu, D. Patriche, B, Stănescu, E. Bădescu, M. Vasile.

Revista de Medicină Modernă 2009;XVI (4):177-181.

30. Rolul axei hipotalamo-hipofizo-corticosuprarenaliene în patogeneza tulburărilor de

anxietate.

D.Vasile, O.Vasiliu.

Revista de Medicină Militară 2009; 2(CXII):35-40

31. Sindroame psihotice induse de agenţii farmacologici psihotropi.

D. Vasile, O.Vasiliu, A.G. Mangalagiu, B.M.Petrescu, B.Stănescu, D.M.Năstase.

Revista de Medicină Militară 2009;3(CXII):33-38

32. Evaluarea mecanismelor defensive la pacientii cu dublu diagnostic- fibromialgie si

tulburare mixta depresiv-anxioasa

D.Vasile, O.Vasiliu, A.G.Mangalagiu, M.L.Vasile, G.Grigorescu, B.Vasile, M.Terpan,

B.M.Petrescu, D.M.Năstase

Revista de Medicină Militară 2010; 2 (CXIII): 43-47

33. Abordari psihofarmacologice ale sistemului melatoninergic in tulburarile hipnice

D.Vasile, O.Vasiliu, A.G.Mangalagiu, D.M.Nastase, B.Vasile, E.Badescu, M.Vasile,

M.Terpan


34. Abordari psihofarmacologice in preventia secundara a stresului posttraumatic

D.Vasile, O.Vasiliu, A.G.Mangalagiu, D.Ungureanu, B.Vasile, M.Vasile, D.M.Nastase


35. Dictionar de psihiatrie- Alogia

D.Vasile, O.Vasiliu

Revista de Medicină Militară 2010;4(CXIII):22

36. Cognitive-behavioral therapy efficacy in major depression with associated axis II

risk factor for negative prognosis

D.Vasile, O.Vasiliu

Recent Advances in Risk Management, Assessment and Mitigation, 2010, 460-464

37. Quality of life changes through risk factors reduction focused psychotherapy in

cancer diagnosed patients

D.Vasile, O.Vasiliu, D.G.Ojog


38. Burn-out in a sample of physicians, nurses and medical students- risk factors

analysis D.Vasile, O.Vasiliu, D.G.Ojog


22

39. Cognitive risk factors for releapse in chronic schizophrenia D.Vasile, O.Vasiliu, A.G.Mangalagiu


40. Evaluation of the self-aggressive behavior risk factors in oncologic patients

D.Vasile, O.Vasiliu, G.Grigorescu


41. Suicide risk factors assessment in schizophrenia.

D.Vasile, O.Vasiliu, M.Vasile


42. Analiza eficacităţii medicaţiei psihotrope în coşmarurile asociate tulburării de stres

posttraumatic

O.Vasiliu, D.Vasile, NF Taină, AG Mangalagiu, A Bănică

Revista de Medicină Militară 2011; 3 (CXIV): 31-38.

43. Dictionar de psihiatrie- Anhedonia

D.Vasile, O.Vasiliu

Revista de Medicină Militară 2011; 3 (CXIV): 24

44. Evaluation of the mood-stabilizers associated neurocognitive effects in bipolar

patients

D.Vasile, O.Vasiliu, A.G.Mangalagiu, D.G.Ojog,

Therapeutics, Pharmacology and Clinical Toxicology 2011;XV(4):304-308

45. Augmentation strategies in selective serotonin reuptake inhibitors resistant

obsessive-compulsive disorder- a systematic literature review.

D.Vasile, O.Vasiliu, A.G.Mangalagiu, D.G.Ojog.

Therapeutics, Pharmacology and Clinical Toxicology 2011;XV(2):83-92

46. Comparative analysis of dual serotoninergic and noradrenergic antidepressants in

double depression with alcohol dependence

D.Vasile, O.Vasiliu, A.G.Mangalagiu, G.A.Sopterean, R.E.Bratu

Romanian Journal of Psychopharmacology 2013;13(1):7-15

47. Comparative analysis of alprazolam, buspirone and pregabalin as add-on agents in

partial responsive generalized anxiety disorder

O.Vasiliu, D.Vasile

Romanian Journal of Psychopharmacology 2015;15(1):26-30.

48. The new wave of atypical antipsychotics- Really new drugs or just another “Me,

Too” drugs?

D.Vasile, O.Vasiliu


49. Analysis of antidepressant drugs impact over quality of life in old-age onset

depressive disorder

O.Vasiliu, D.Vasile, D.G.Vasiliu, F.Vasile


50. Pharmacologic treatment in old-age major depression. A systematic literature review

O.Vasiliu, V.Voicu, D.Vasile


23

51. Risk factors and quality of life in late- life depressive disorders

O.Vasiliu, D.Vasile

Romanian Journal of Military Medicine 2016;CXIX(3):24-28.

STUDII PUBLICATE ÎN REZUMAT ÎN REVISTE ȘI VOLUME ALE UNOR

MANIFESTĂRI ȘTIINȚIFICE CU ISBN/ISSN

1. Semnificatia psihopatologicã a comportamentului autoagresiv la tineri

Al 17 -lea Simpozion Danubian de Psihiatrie, Timisoara, 24-27 aprilie, 1996

M.D. Gheorghe D. Vasile, Carmen Andreescu, Gabriela Grigorescu, Arina Baloescu, I. Pascu

2. Depresia refractarã conotaţii terapeutice

Al 17 -lea Simpozion Danubian de Psihiatrie, Timisoara, 24-27 aprilie, 1996

M.D. Gheorghe, D. Vasile, Carmen Andreescu, Gabriela Grigorescu

3. Conotatii psihopatologice ale comportamentului autoagresiv la tineri Congresul National de Toxicologie Clinica, Bucuresti, 13-15.11.1996, Vol. rez. pg.41.

M.D.Gheorghe, D. Vasile, Emilia Lungut, Gh. Clejan

4. Utilizarea Haloperidolului la schizofrenii somalezi – particularitati posologice Conferinta Nationala de Psihiatrie, Bucuresti, 24-25 oct 1997, vol. rez.p.75

D. Vasile, M.D. Gheorghe, E. Lungut, G. Grigorescu

5. Clinical-Therapeutical Aspects and Encountered with the local Schizophrenic

Patients within the “Restore Hope” Somalia Mission Congresul de Medicinã Militarã Balcanicã, Sofia, mai 1997, Vol. rez.

D. Vasile, M.D.Gheorghe

6. Clinical Features of Khat –intoxication Encountered in the Somali People

3-rd Congress of Balkan Military Medical Committee, Athens, 10-13 May, 416,1998

D. Vasile

7. Alcohol Neurotoxicity: electrophisiology-psychopathology


Emilia Lunguţ, D. Vasile

8. New Therapeuthical Approaches to the First Psychotic Episode in the Soldiers


M.D.Gheorghe, D. Vasile, S.Isacu

9. Serotoninergic Syndrome – a present complication in the psychiatric practice


M.D.Gheorghe, D. Vasile

10. Socio-cultural paricularities of the self-aggressive behaviour in the soldiers


D. Vasile, Gabriela Grigorescu, M.D.Gheorghe

11. Suicidal attempt in the army- romanian experience 20

th Congress of the International Association for Suicide Prevention, 6-10 nov 1999, Athens,

Greece, Abstract Book p.125

M.D.Gheorghe, D. Vasile, A. Baloescu, G.Grigorescu

24

12. New Therapeutical Approaches of Heroin Withdrawal in Polysubstance

Dependence 4

th Congress of Balkan Military Medical Committee, Bucharest, June 6-10, Abstract Book,

pg. 191, 1999

Vasile D., M.D.Gheorghe, V.Voicu

13. Restore Hope –Psychiatric Morbidity Structure and Some Peculiarities of Main

Psychopathological Entities, 4th

Congress of Balkan Military Medical Committee,

Bucharest, June 6-10, Abstract Book, pg. 235, 1999

Vasile D.

14. Evoked motor responses of the brain, spinal cord and roots – clinical aproach

5th

Congress of the Balkan Military Medical Committee Ankara, Turkey 25-28 sept. 2000-

Abstract Book pag. 111

E. Lunguţ, D. Vasile

15. The personality features among heroin withdrawal impatients

5th

Congress of the Balkan Military Medical Committee Ankara, Turkey 25-28 sept. 2000-

Abstract Book pag. 144

D. Vasile , M.D. Gheorghe

16. Comportamentul autoagresiv la tineri – caracteristici si management terapeutic

Psihiatria 2000, Congres national cu participare internationala, 4-7 oct 2000, Iasi

D. Vasile, M.D. Gheorghe, G. Grigorescu, A. Baloescu

17. Cholinergic therapies used for improving cognitive deficit in Alzheimer disease

Alzheimer Europe 11th

Conference 10 – 12th

June 2001, Bucharest, Romania

D. Vasile, M.D. Gheorghe

18. Zyprexa in the treatment of behavioral symptoms in dementia

7th

World Congress of Biological Psychiatry – 1-6 July 2001 Berlin, Germany- Abstract Book

pag. 123

M.D. Gheorghe, D.Vasile

19. Efficacy and tolerability of Solian in acute exacerbation of schizophrenia

7th

World Congress of Biological Psychiatry – 1-6 July 2001 Berlin, Germany- Abstract Book

pag. 301

M.D. Gheorghe, D.Vasile

20. Rolul tomoscintigrafiei cerebrale de perfuzie in diagnosticul dementelor

Primul congres national de medicina nucleara cu participare internationala, Bucuresti, 03-

06.10.2001- Abstract Book, pag.58

Adriana Petrescu, George Marinescu, D. Vasile

21. Fenomenul de recadere in consumul de heroina postsevraj

Conferinta Nationala « Terapie si management in psihiatrie », Craiova, 25-27.10.2001-

Abstract Book, pag.81

D. Vasile, R.Ciurea

22. Electrodiagnosis of diabetic neuropathy (VCM,VCS, F wave and H reflex)

6th Congress of Balkan Military Medical Committee, Plovdiv, Bulgaria, 01-03.10.2001,

Abstract Book, pag.21

E. Lungut, D.Vasile

25

23. Heroin dependence- personality disorder, a dual diagnosis increasing treatment

costs

Third Regional Meeting, Financing Mental and Addictive Disorders in Central and Eastern

Europe, Bucharest, November 23-25, 2001, Abstract Book, pag.22

D. Vasile, M.D. Gheorghe

24. Abordari terapeutice in dependenta de heroina

5th Xenobiotic Metabolism and Toxicity Workshop of Balkan Countries, Constanta, 29.05-

01.06.2002, Abstract Book, pag.7

D. Vasile

25. Borderline personality- heroin dependence comorbidity XII World Congress of Psychiatry, 24-29.08.2002, Yokohama, Japan, Abstract Book, pag.38

D. Vasile, M.D.Gheorghe, R. Ciurea

26. The efficacy of donepezil in Alzheimer’s disease cognitive deficit

Abstracts of the 15th Congress of the European College of Neuropsychopharmacology,

Barcelona, Spain, October 5-9, 2002, S374

D. Vasile, M.D. Gheorghe.

27. Antisocial personality disorder- heroin dependence comorbidity

Abstracts of the 15 th Congress of the European College of Neuropsychopharmacology,

Barcelona, Spain, October 5-9, 2002 , S392.

D. Vasile, M.D. Gheorghe, R. Ciurea, S. Paraschiv

28. Comparative Analysis of the Antipsychotics Side Effects in the Onset of

Schizophrenia in Conscripts

“Balkan Military Medical Review”, 2002, 5 (1-2):24-29

D.Vasile, O.Vasiliu, S.Paraschiv, C.A.Sirbu, M.D.Gheorghe

29. Imaging contribution in long term monitoring of cerebral hydatosis

“Balkan Military Medical Review”, 2002, 5 (1-2): 63-71

C.A. Sîrbu, D. Vasile, F. Cristea, R. Munteanu, C. Constantin, D. Constantin

30. Utilizarea Exelonului în ameliorarea deficitului cognitiv în Boala Alzheimer

AEP Spring Symposium, Roma , april 24-26, 2003

D.Vasile, R. Ciurea, M.D.Gheorghe

31. The evaluation of personality disorders in soldiers with self-injuring behavior 8

th Congress of Balkan Military Medical Committee, Cluj, 2003

O Vasiliu, D. Vasile

32. Trazodone as an optimal treatment for the sexual disfunctions in depressed

patients

8th

Congress of BMMC, Cluj, 2003

O Vasiliu, D. Vasile

33. Efficacy of the mirtazapine treatment in the neoplasm associated pain 8

th Congress of BMMC, Cluj, 2003

D. Vasile, O Vasiliu

34. Treatment of neoplasm secondary depression using mirtazapine

8th


26


35. The importance of the family background in heroin-dependence primary and

secondary prophylaxis

8th



36. Weight gain as a secondary effect in typical and atypical antipsychotic treatment of

schizophrenia

8th



37. Cardiovascular side effects caused by the administration of atypical antipsychotics

8th



38. The onset of action of mirtazapine in a group of military personnell 8

th Congress of BMMC, Cluj, 2003


39. The efficacy of reboxetine in the treatment of inhibited depression

8th

Congress of BMMC Cluj, 2003


40. Noncompliance factors in schizophrenia treatment

9th

Congress of BMMC, Antalya, 2004


41. The importance of self image distorsions in depressive disorders with suicidal

attempts

9th

Congress of BMMC", Antalya, 2004


42. Defense mechanisms in patients with oncological pathology

9th


O Vasiliu , D. Vasile

43. Sleep quality improvement in depressed patients receiving Trazodone

9th



44. Multiaxial diagnosis and quality of life assessment in Alzheimer disease

9th


D. Vasile, O. Vasiliu

45. Improvement of depressive symptomatology in the onset of schizophrenia

9th



46. Demographic data analysis in heroin dependence patients

9th



27

47. Correlation between personality features and adjustment disorders in conscripts

9th



48. Trazodone in sexual dysfunctions of depressed patients receiving selective serotonin

reuptake inhibitors

WPA International Congres, Florenta, noiembrie, 2004


49. The effect of atypical antipsychotics on depressive symptomatology in schizophrenia

17th

ECNP Congress, Stockholm, octombrie, 2004


50. Atypical antipsychotics- Side effects profile

International Congress of Biological Psychiatry, Sydney, 2004


51. Atypical antipsychotics agents in acute psychotic disorder with affective features

The 8th

World Congress of Biological Psychiatry, Vienna, Jul 2005

The World Journal of Biological Psychiatry 2005;6(Suppl.1):320

D. Vasile, O.Vasiliu, M. Gheorghe

52. The effectiveness of intravenous Trittico in Major Depresive Episode

The 8th

World Congress of Biological Psychiatry, Vienna, Jul 2005

The World Journal of Biological Psychiatry 2005;6(Suppl.1):179

M. Gheorghe, D. Vasile, O.Vasiliu

53. Treatment in Alzheimer dementia with depressed mood

XIII World Congress of Psychiatry, Cairo, September, 10-15, p. 532, 2005

D. Vasile, O. Vasiliu, A. Apetroaei, S. Paraschiv, M.D. Gheorghe

54. Efficacy, safety and compliance in the long acting atypical anipsychotic treatment

XIII World Congress of Psychiatry, Cairo, September, 10-15, p. 716, 2005

M.D.Gheorghe, D. Vasile, G. Grigorescu

55. Bupropion as craving decreasing agent in alcohol dependent patients

11th Congress of Balkan Military Medical Committee, June 18-22, 2006, Athens

Vasile D., Vasiliu O., Gheorghe M.D., Ivanov P., Paraschiv S.

56. Depressive symptomatology cluster analysis

11th Congress of Balkan Military Medical Committee, June 18-22, 2006, Athens

Vasile D., Vasiliu O., Vasile M., Ojog D.

57. Defense mechanism analysis in conscripts diagnosed with adjustment disorders

11th Congress of Balkan Military Medical Committee, June 18-22, 2006, Athens, p. 100

Vasiliu O, Vasile D, Varzaru C, Ojog D.

58. Coping mechanism as prognosis factors in the cognitive behaviour therapy of

major depressive disorder


Vasiliu O, Vasile D, Varzaru C, Ojog D.

28

59. Psychotherapeutical crisis interventions in depressive disorders with

suicidal ideation

11th Congress of Balkan Military Medical Committee, June 18-22, 2006, Athens, p.33

Vasiliu O, Vasile D, Ivanov P, Paraschiv S.

60. Determination of quetiapine in urine samples by GC-MS method


Ionica M, Macovei R, Vasile D, Caragea D, Forje M.

61. Aripiprazole efficacy in chronic schizophrenia with prominent negative symptoms


Vasile D., Vasiliu O, Gheorghe M.D.

62. Augmenting antidepressive psychopharmacological approach with cognitive-

behavioral therapy in refractory major depressive disorder


Vasiliu O, Vasile D, Sarmache M., Vasile M.

63. Psychotropic drugs discontinuation syndromes in clinical practice

Balkan Military Medical Review, 9, January, 38-41, 2006

D. Vasile, O. Vasiliu, M.D.Gheorghe, P. Ivanov, D. Ojog D

64. Nonbenzodiazepine and benzodiazepine hypnotic comparative analysis in organic

conditions secondary insomnia

The Journal of the Association of European Psychiatrists, 14th AEP Congress, Nice, 4-8

march 2006, S152

Vasile D., Vasiliu O., Ojog D., Sarmache M.,Vasile M.,Paraschiv S.

65. Effectiveness of cognitive behavioural therapy in dual diagnosis: panic disorder

and major depressive disorder


march 2006, S152

Vasile D., Vasiliu O., Ivanov P., Paraschiv S.

66. Comorbidity association study in heroin dependent patients


march 2006, S144

Vasile D., Vasiliu O., Ivanov P., Varzaru C., Ojog D., Paraschiv S.

67. Antidepressant switch efficacy in selective serotonin reuptake inhibitors resistant

major depressive disorder

European Neuropsychopharmacology, 19th ECNP Congress Paris, France, 16-20 September,

2006, S324

Vasiliu O, Vasile D, Miclos M, Ivanov P

68. Amisulpride association to selective serotonin reuptake inhibitors in severe major

depressive episodes with psychotic features

European Neuropsychopharmacology, 19th ECNP Congress Paris, France, 16-20 September,

2006, S362

Vasiliu O, Vasile D, Paraschiv S, M. Miclos, Ivanov P.

69. Managementul farmacoterapeutic al pacientilor psihotici agresivi

Terapie si management in psihiatrie, 28 septembrie – 1 octombrie, 2006, Craiova, p.27-28

29

Vasile D., Vasiliu O, Sarmache M, Vasile M.

70. Comorbiditati addictive in tulburarea de panica


Vasiliu O, Vasile D, Ojog D.

71. Evaluarea calitatii vietii la pacientii cu dementa vasculara


Vasile D, Vasiliu O, Varzaru C, Ivanov P.

72. Prim episod schizofrenic – Evaluare SPECT cerebrala de perfuzie pre si post-

tratament cu antipsihotice atipice

Al 2-lea Congres National de Medicina Nucleara 8-11.11.2006, Bucuresti, p.110-111

Rimbu A., Marinescu G, Mititelu R, Ghita S, Mazilu C, Vasile D, Baloescu A, Tudor C,

Isacu S, Vasiliu O, Gheorghe M.D, Codorean I.

73. Compliance Therapy as Increasing Adherence Method for Alcohol Addiction

12th Congress of BMMC, 24-28 iunie 2007, Poiana Brasov

D. Vasile, O.Vasiliu, S.Paraschiv, M. Terpan

74. New methods for mood disorders treatment



75. Ethiological considerations over delirium due to general medical conditions


D. Vasile, O.Vasiliu, M. Vasile, M. Sarmache

76. Comparative analysis of second generation antipsychotics in the treatment of

negative symptoms in chronic schizophrenia


D. Vasile, O. Vasiliu, S. Paraschiv, M. Terpan

77. Bupropion administration in major depressive with alcohol dependence dual

diagnosis


D. Vasile, O.Vasiliu, D. Ojog, M.Terpan

78. Aripiprazole administration in schizoaffective disorder, bipolar type


D. Vasile, O. Vasiliu, M. Sarmache, M. Vasile

79. Anxiety disorders screening in general internal medicine clinic hospitalised patients


D. Vasile, O. Vasiliu, R. Brisculescu, D. Ojog

80. Cognitive behavioural therapy in generalised anxiety disorder


O. Vasiliu, D. Vasile, M. Vasile, M. Sarmache

81. Defense mechanisms analysis in somatoform disorders


O. Vasiliu, D. Vasile, R. Brisculescu, D. Ojog

82. Hypothyroidism presenting as psychosis: „mixedema madness” case report

30


C. Spiroiu, A.E.Ranetti, A. Mazilu, D. Vasile, C.Tudor, O.Vasiliu

83. Cognitive-behavioural therapy and antidepressant drug treatment in irritable bowel

syndrome

Journal of Czech and Slovak Psychiatry, vol.104,suppl.2, XIV World Congress of Psychiatry,

20-25 sep 2008, Prague, p.933

D. Vasile, O. Vasiliu, D. Patriche, P.Ivanov, B. Stanescu

84. The influence of coping mechanisms over the evolution of acute stress disorder


20-25 sep 2008, Prague, p.1145

D. Vasile, O. Vasiliu, M. Vasile, D. Patriche, D. Ojog

85. Crisis therapy intervention in panic disorder


20-25 sep 2008, Prague, p.1235

D. Vasile, O. Vasiliu, M. Vasile, O. Cretu, M. Terpan

86. Guided imagery applications in breast cancer related mixed anxious-depressive

disorder


20-25 sep 2008, Prague, p.1461

D. Vasile, O. Vasiliu, M. Vasile, M. Terpan, D. Ojog

87. The management of alcoholism dependence in patients with oncologic disease


20-25 sep 2008, Prague, p.1461

D. Vasile, O. Vasiliu, O. Cretu, P.Ivanov, B. Stanescu

88. Evaluarea cresterii nivelului de prolactina la pacientii tratati cu antipsihotice atipice.

Al 13-lea Simpozion National de Psihoneuroendocrinologie, Cluj-Napoca, 2006

I. Paul, D. Vasile, O. Vasiliu, A. Raceala

89. Scăderea toleranţei la glucoză la pacienţii cu un prim episod de schizofrenie in

tratament cu antipsihotice atipice

Al 13-lea Simpozion National de Psihoneuroendocrinologie, Cluj-Napoca, 2006

A. Raceala, D. Vasile, O. Vasiliu, P. Ivanov, L. Dumitrache.

90. Provocări etice în psihooncologie

A VII-a Conferinţă Naţională de Bioetică, Bucureşti, 2011

O.Vasiliu, D.Vasile, A.G.Mangalagiu, N.F.Taină, A.Bănică, M.Blându, D.G.Ojog

91. Aspecte etice ale consimţământului informat în cazul pacienţilor cu boala Alzheimer

A VII-a Conferinţă Naţională de Bioetică, Bucureşti, 2011

O.Vasiliu, D.Vasile, A.G.Mangalagiu, N.F.Taină, A.Bănică, M.Blându, D.G.Ojog

92. Diagnosticul multiaxial în tulburările somatoforme

Zilele Spitalului Universitar de Urgență Militar Central „Dr.Carol Davila”, 2012, Volum de

rezumate

D.Vasile, O.Vasiliu, AG Mangalagiu, C.Tudor, D.Ungureanu, BM Petrescu, V. Bogdan, G.

Grigorescu, M. Blandu

93. Efficacy of rivastigmine patch in mixed severe neurocognitive disorders

Zilele Spitalului Universitar de Urgență Militar Central “Dr. Carol Davila”, 2014

31

D.Vasile, O.Vasiliu, M.B.Petrescu.

94. Improving treatment adherence in schizophrenia diagnosed patients by using long

acting injectable antipsychotics

Carol Davila University Central Emergency Military Hospital Scientific Days, 6th Ed.

Romanian Journal of Military Medicine 2016; vol.CXIX(Suppl.):5

O.Vasiliu, D.Vasile, A.G.Mangalagiu, B.M.Petrescu, C.Tudor, C.Candea, R.E. Bazac-Bratu,

F.T.Androne, A.F.Alboaie, M.Patrascu, E.A.Patrascu.

95. Primary prevention in unipolar depression



A.Nistor, T.Hara, C.King, F.Blebea, A.Iftodi, Corina Tudor, O.Vasiliu, D.Vasile

96. Psychiatry and terrorism.



C.Candea, D.Vasile, O.Vasiliu, B.Petrescu, A.Mangalagiu, Irina Candea, A.M.Badic

97. Transcultural psychiatry.



C.Candea, D.Vasile, O.Vasiliu, B.Petrescu, A.Mangalagiu, irina Candea, A.M.Badic.

98. Predictors for treatment response in old age major depressive disorder.

The International Conference “Psychology and the realities of the contemporary world” 7th

Ed., Bucharest.

Romanian Journal of Experimental Applied Psychology, 2016; 7 (Special Issue 2):74

O.Vasiliu, D.G.Vasiliu, D.Vasile.

99. Cognitive behaviour therapy in young patients with alcohol related disorders.

The International Conference “Psychology and the realities of the contemporary world” 7th

Ed., Bucharest.

Romanian Journal of Experimental Applied Psychology, 2016; 7 (Special Issue 2):75

O.Vasiliu, D.G.Vasiliu, D.Vasile.

100. Atipical side effects of antipsychotics – risc factor for noncompliance in first episode

of schizophrenia

9th World congress of Biological Psychiatry, The World Journal of Biological Psychiatry,

vol.10-supplement 1-2009, pg.281

R. Grigorescu, V. Voicu, D. Vasile, G. Grigorescu

101. Cognitive impairment profile in schizophrenia. 9th World congress of Biological

Psychiatry.

The World Journal of Biological Psychiatry, 2009;10 (Suppl.1):281-282

G. Grigorescu, D. Vasile, C. Tudor, R. Grigorescu

102. Efficacy of aripiprazole vs. quetiapine for the treatment of hostility in acute

patients with schizophrenia. 9th World congress of Biological Psychiatry.

The World Journal of Biological Psychiatry, 2009;10 (Suppl.1):282.

D. Vasile, G. Grigorescu, C. Tudor, O. Vasiliu, R. Grigorescu

103. Duloxetine versus escitalopram in the treatment of major depressive disorder and

generalized anxiety disorder dual diagnosis. 9th World congress of Biological

Psychiatry.

The World Journal of Biological Psychiatry, 2009;10 (Suppl.1):384

32

D. Vasile, O. Vasiliu, M. Vasile, G. Grigorescu, M. Terpan

104. Milnacipran efficacy in major depressive disorder and alcohol dependence dual

diagnosis. 9th World congress of Biological Psychiatry.


D.Vasile, O. Vasiliu

105. Tianeptine efficacy in the treatment of multiple sclerosis associated anxiety disorder

9th World congress of Biological Psychiatry.


D. Vasile, V. Voicu.

106. 25 years of fluoxetine: how far are we from an optimal treatment for depression?

Therapeutics, Pharmacology and Clinical Toxicology, 2011;XV(Suppl.II):74

N.F.Taina, D.Vasile, O.Vasiliu, A.G.Mangalagiu, B.Stanescu

107. Nightmare pharmacologic treatment in posttraumatic stress disorder- a systematic

literature review

Therapeutics, Pharmacology and Clinical Toxicology, 2011;XV(Suppl.II):74

N.F.Taina, D.Vasile, O.Vasiliu, A.G.Mangalagiu, A.Banica, D.G.Ojog

108. Analiza eficacitatii terapeutice a duloxetinei comparativ cu inhibitorii selectivi ai

recaptării serotoninei în depresia majoră recurentă cu manifestări atipice

Revista de Medicina Militara 2011; CXIV (Suppl):24

V.Daniel, Vasiliu O, Ungureanu Daniela, Tudor Corina, Bogdan V, Mangalagiu AG, Banica

Anisoara, Grosu Georgeta, Meliaca A

109. Quality of life assessment in patients diagnosed with bipolar disorder and alcohol

dependence

International Clinical Psychopharmacology 2011;26e (Suppl.A): 29

D.Vasile, O.Vasiliu, A.G.Mangalagiu,

110. Quetiapine efficacy and tolerability in bipolar II disorder with comorbid cluster C

personality disorder

International Clinical Psychopharmacology 2011;26e (Suppl.A): 29

D.Vasile, O.Vasiliu, G.D.Ojog

111. Familial history of psychotic disorders in patients with bipolar I and II disorder

International Clinical Psychopharmacology 2011;26e (Suppl.A): 29-30

D.Vasile, O.Vasiliu, A.G.Mangalagiu

112. Psychoactive substance induced manic episodes in a population of young patients- a

case series

International Clinical Psychopharmacology 2011;26e (Suppl.A):30

D.Vasile, O.Vasiliu, D.G.Ojog

113. Comparative analysis of duloxetine and SSRIs in oncologic patients with major

depressive disorder. P-10-022.

11th

World Congress of Biological Psychiatry 2013.

D.Vasile, O.Vasiliu, N.F.Taina, R.Bratu, G.Sopterean.

114. Combined naltrexone and cognitive therapy in binge drinking patients with cluster

B personality features. P-17-014.

11th


D.Vasile, O.Vasiliu, A.G.Mangalagiu, B.M.Petrescu, N.F.Taina.

33

115. Agomelatine versus escitalopram in the treatment of elderly patients with post-

stroke depression. P-21-016.

11th


D.Vasile, O.Vasiliu, A.G.Mangalagiu, G.Sopterean, R.Bratu, D.G.Ojog.

116. Metabolic profile of long-acting injectable risperidone versus olanzapine pamoate

in chronic schizophrenia. P-24-003.

11th


D.Vasile, O.Vasiliu.

117. The Efficacy of dual action antidepressants in depressive disorder associated with

systematic lupus erythematosus

Romanian Journal of Psychiatry 2013; XV (Suppl.1):P-51

C.Tudor, O.Vasiliu, M.Zavoianu, G.Grigorescu, A.G.Mangalagiu, D.Vasile, O.Magazin

118. Newly diagnosed Alzheimer Dementia cases in non-psychiatric departments of a

general medical hospital- a liaison psychiatry study

Romanian Journal of Psychiatry 2013; XV (Suppl.1):P-69

D. Vasile, O.Vasiliu, A.G.Mangalagiu, M.Blandu, B.M.Petrescu

119. Analysis of the organic comorbidities in early-onset Alzheimer Dementia patients

Romanian Journal of Psychiatry 2013; XV (Suppl.1)

D.Vasile, O.Vasiliu, A.G.Mangalagiu, B.M.Petrescu, M.Blandu

120. Galantamine efficacy and tolerability in amnestic mild cognitive impairment. P-07-

021.

11th

World Congress of Biological Psychiatry 2013

D.Vasile, O.Vasiliu, A.G.Mangalagiu, G.Sopterean, R.Bratu

121. Efficacy and tolerability of venlafaxine switch in serotonin selective reuptake

inhibitors treated patients with partial response. P-22.

Abstracts of the 12th World Congress of Biological Psychiatry 2015

D.Vasile, O.Vasiliu, D.G.Vasiliu, G.A.Sopterean, R.E.Bratu, F.Androne, F.Vasile

122. Comparative efficacy of bupropion and duloxetine in depressive disorder due to

Parkinson’s disease. P-15.

Abstracts of the 12th World Congress of Biological Psychiatry 2015

D.Vasile, O.Vasiliu, D.G.Vasiliu, F.Androne, F.Vasile

123. Delirium and depression: relationship and clinical overlap in elderly people.

Abstracts of 20th Congress of Balkan Military Medical Committee.

Balkan Military Medical Review 2015;18(5):e77

D.Vasile, B.M.Petrescu, O.Vasiliu, A.Mangalagiu, C.Candea

123. Quality of life assessment in schizophrenia diagnosed patients with predominant

negative symptoms. T273.

5th Schizophrenia Research Society Conference 2016

D.Vasile, O.Vasiliu, D.G.Vasiliu, F.Vasile

124. Pharmacologic management in cases of dual diagnosis- schizophrenia and alcohol

use disorder. M108.



34

125. Aggressivity management in schizophrenia diagnosed patients using

calcium channel alpha2-delta ligands. S50.



CITĂRI ÎN SISTEM ISI

Lucrările citate:

Anand R, Geffen Y, Vasile D, Dan I. An open-label tolerability study of BL-1020

antipsychotic: a novel gamma aminobutyric acid ester of perphenazine. Clin

Neuropsychopharmacol 2010;33(6):297-302. – 5 citări

Baloescu A, Vasile D,.Gheorghe M.D, Grigorescu G.Side effects of atypical antipsychotics –

prediction for factor for compliance. European Neuropsychopharmacology, 19th ECNP

Congress Paris, France, 16-20 September, 2006, S404 – o citare

D.Vasile, O.Vasiliu, D.Ojog, R. Brisculescu, M. Vasile. Cognitive-behavioral therapy

efficacy in major depressive disorder and histrionic personality disorder dual diagnosis. The

16th AEP European Congress of Psychiatry, Nice, April 5 – 9, 2008 – o citare

Vasile D, Vasiliu O, Vasile M.L, Terpan M, Ojog DG. Agomelatine versus selective

serotoninergic reuptake inhibitors in major depressive disorder and comorbid diabetes

mellitus. 24th Congress Meeting of ECNP, Paris, 2011. European Neuropsychopharmacology

2011;21(Suppl.3):S383-384 – o citare

D.Vasile, O.Vasiliu. Management of Cognitive symptoms in dementia associated with

Parkinson’s disease. North Atlantic University Union Proceedings of the World Medical

Conference, 2010, 284-286 – o citare

Grafic 1. Sursa informațiilor: apps.webofknowledge.com, accesat în data de 07/01/2017

D.Vasile, O.Vasiliu, M.Vasile, M.Sarmache. Improving the quality of life in patients with

malignant tumors using cognitive psychotherapy. The 16th AEP European Congress of

Psychiatry, Nice, April 5 – 9, 2008 – o citare

În plus:

D. Vasile, O. Vasiliu, D. Ojog, M.D. Gheorghe. Risperidone long-acting IM formulation in

high risk of non compliance bipolar patients. Proceedings of the 19th

ECNP Congress.

European Neuropsychopharmacology 2006;16(4):S413-414

Lucrare citată în Akiskal HS, Tohen M (Eds). Psychopharmacotherapy. Caring for patient. 2nd

Ed. John Wiley&Sons, Oxford, 2011.

35

PREMII OBȚINUTE

-ECNP Regional Poster Award: The effects of the adenosinic agonists and antagonists on

behaviour and on EEG activityin rats. I.Cristescu, T.Raducanu, A.Zugravu, D.Vasile,

S.Stoleru. 7th ECNP Regional Meeting 2002, Bucharest, Romania

-11th Congress of Balkan Military Medical Committee Best Poster Presentation Award:

Augmenting Antidepressive Psychopharmacological Approach with Cognitive-Behavioral

Therapy in Refractory Major Depressive Disorder. Vasiliu O, Vasile D, Sarmache M, Vasile

M. 11th Congress of Balkan Military Medical Committee, 2006, Athens, Greece

-Balkan Military Medical Committee: First Prize from Romanian delegation for poster

presentation during 12th Congress of BMMC. 2007, Poiana Brasov, Romania

-13th Congress of Balkan Military Medical Committee: First Prize Poster Award: Psychiatric

Comorbidity in Somatoform Disorders. 2008, Kusadasi, Turkey

MEMBRU ÎN ASOCIAȚII PROFESIONALE ȘI ȘTIINȚIFICE

-Secretar General al Balkan Military Medical Committee

-Honorary President of the Balkan Military Medical Committee

-Vicepreședinte al Asociației Medicilor și Farmaciștilor Militari din România

-Membru al Comisiei Interministeriale de Luptă Antidrog

-Membru al European College of Neuropsychopharmacology

-Membru al Association of European Psychiatrists

-Membru al International Early Psychosis Association

ACTIVITATE EDITORIALĂ

-redactor șef adjunct al Revistei de Medicină Militară (2 ani)

-reviewer la European Neuropsychopharmacology (2 ani)

Date post:	12-Jun-2020
Category:	Documents
Upload:	others
View:	4 times
Download:	0 times

C U R R I C U L U M V I T A E Vasile Daniel Conferențiar...

Documents